Scott Schutt

Scott Schutt currently serves as Regional Pediatric Oncology Specialist at Fennec Pharmaceuticals Inc since July 2022. Prior experience includes roles at Biogen as Sr. Territory Business Manager, where Scott facilitated the launch of Aduhelm for Alzheimer's Disease, and at Lundbeck as BioPharmaceutical Account Manager, focusing on the launch of Vyepti in neurology. Scott's career further encompasses significant contributions at Teva Pharmaceuticals as Sr. Neuroscience Sales Specialist, where the launch of multiple products in neurology was achieved, and at Novartis, where Scott introduced several biologics for various specialties. Earlier professional experience includes management roles in the funeral service industry, with education from the University of Central Oklahoma, earning a Bachelor of Science in Mortuary and Health Sciences.